Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06495138 · ClinicalTrials.gov registry record · NA

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
138
Enrollment target
1
Study location

NCT06495138 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by Emory University. The registered enrollment target is 138 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06495138, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
138 participants
Enrollment target
1
Study location

Study Summary

The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis.

Conditions Studied

Multiple Sclerosis

Interventions

  • DEVICE StableEyes

Study Locations (1)

Georgia

  • Emory Univeristy - Atlanta

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2025-04-21
Est. Completion 2027-03
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06495138

The ClinicalTrials.gov registry entry for NCT06495138 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (76% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which StableEyes is the first listed.

NCT06495138 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06495138 about?

NCT06495138 is a clinical study titled "Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis". The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis...

What is the current status of trial NCT06495138?

This trial is currently recruiting. It is a NA study. The enrollment target is 138 participants. The study started on 2025-04-21. Estimated completion is 2027-03.

What conditions does trial NCT06495138 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06495138?

The interventions under investigation include: StableEyes (DEVICE).

Who is sponsoring clinical trial NCT06495138?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06495138 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.